US20110009943A1 - Delivery system with medical device release by evertable sleeve - Google Patents

Delivery system with medical device release by evertable sleeve Download PDF

Info

Publication number
US20110009943A1
US20110009943A1 US12/833,604 US83360410A US2011009943A1 US 20110009943 A1 US20110009943 A1 US 20110009943A1 US 83360410 A US83360410 A US 83360410A US 2011009943 A1 US2011009943 A1 US 2011009943A1
Authority
US
United States
Prior art keywords
medical device
distal end
proximal
delivery system
inner
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/833,604
Inventor
Ram H. Paul
Brain C. Case
Brian P. Feng
Frances Kristen Bailey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Medical Technologies LLC
Original Assignee
Cook Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US22436009P priority Critical
Application filed by Cook Inc filed Critical Cook Inc
Priority to US12/833,604 priority patent/US20110009943A1/en
Assigned to COOK INCORPORATED reassignment COOK INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CASE, BRIAN C, PAUL, RAM H, FENG, BRIAN P, BAILEY, FRANCES KRISTEN
Publication of US20110009943A1 publication Critical patent/US20110009943A1/en
Assigned to COOK MEDICAL TECHNOLOGIES LLC reassignment COOK MEDICAL TECHNOLOGIES LLC CONFIRMATORY ASSIGNMENT Assignors: COOK INCORPORATED
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421Cannulas
    • A61B2017/3435Cannulas using everted sleeves

Abstract

A medical device delivery system has a tubular member defining a passageway and an inner member slideably disposed within the passageway. An expandable intraluminal medical device is disposed on a chamber of the inner member, and an evertable sleeve is attached to the inner member proximal to the chamber and to an inner surface of the tubular member. Relative movement between the tubular and outer members moves the evertable sleeve from a first position substantially overlying the expandable intraluminal medical device to a second position substantially proximal to the chamber.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application Ser. No. 61/224,360, filed on Jul. 9, 2009, the entire contents of which is incorporated into this disclosure by reference.
  • FIELD
  • The disclosure relates generally to the field of intraluminal medical devices. More particularly, the disclosure relates to delivery systems for deploying intraluminal medical devices at a point of treatment within a body vessel.
  • The technologies described herein are useful in the delivery and deployment of various types of intraluminal medical devices, including stents, stent grafts, occluders, valve devices, expandable filters, and others.
  • BACKGROUND
  • Minimally invasive techniques and instruments for placement of intraluminal medical devices have been developed over recent years and are frequently used to deliver and deploy an intraluminal medical device at a desired point of treatment. In these techniques, a delivery system is used to carry the intraluminal medical device through a body vessel to the point of treatment. Once the point of treatment is reached, the intraluminal medical device is deployed from the delivery system. The delivery system is subsequently withdrawn from the point of treatment and, ultimately, the body vessel.
  • A wide variety of intraluminal medical devices that utilize minimally invasive technology has been developed and include stents, stent grafts, occlusion devices, infusion catheters, prosthetic valves, and the like. These devices are frequently used in a variety of treatment procedures. For example, self-expandable stents are used to provide support to various vessels and ducts in the cardiovascular and gastrointestinal systems. Also, prosthetic valves, including prosthetic venous valves, are used to introduce or restore a valving function to a body vessel.
  • Loading an intraluminal medical device into and deploying the device from a conventional delivery system involves relative movement between the intraluminal medical device and a sheath or other outer tubular member that maintains the device in a compressed state during navigation to the point of treatment. During a loading operation, the intraluminal medical device typically is concentrically oriented with an inner dilator. The dilator and intraluminal medical device are then slidingly inserted into a surrounding sheath. During deployment, relative movement between the dilator and sheath is used until the intraluminal medical device is fully exposed. Typically, the dilator and intraluminal medical device are caused to slide out of the sheath, either by retraction of the sheath, advancement of the dilator, or a combination of both. Eventually, the sheath is no longer able to maintain the device in its compressed state due to the change in relative position(s), and the intraluminal medical device is deployed from the dilator to take its implanted position at the point of treatment within the body vessel.
  • The friction that occurs between the intraluminal medical device and the inner surface of the surrounding sheath presents an opportunity for damage to occur to the intraluminal medical device. This is particularly true for intraluminal medical devices that include a graft or other material attached to a support frame, such as stent grafts, valve devices with attached leaflets or other valve functional member, tissue graft devices, graft-based occluders, and other devices. If an excessive amount of friction occurs, the attachment between the graft or other material and the support frame can be damaged, which might affect performance of the device. Use of a tacky valve or valve component can also present additional challenges during loading and/or deployment. Damage to the graft or other material itself might also occur.
  • Friction within delivery systems poses a risk for intraluminal medical devices that require an input of force to achieve intraluminal expansion, such as balloon expandable stents and similar devices, but the problem is of particular concern for self-expandable intraluminal medical devices due to the primary functional role played by the sheath in maintaining these devices in their compressed configurations prior to deployment. With a sheath that provides the constraining force that prevents expansion, friction during relative movement of the dilator or other carrier device and the sheath is a necessary result.
  • Accordingly, a need exists for a delivery system with an improved release mechanism for expandable intraluminal medical devices.
  • BRIEF SUMMARY OF DESCRIBED EMBODIMENTS
  • Medical device delivery systems are described.
  • A delivery system according to a first embodiment comprises a tubular member having a proximal end defining a proximal opening, a distal end defining a distal opening, and an inner surface defining a passageway extending between the proximal and distal openings; an inner member slideably disposed within the passageway of the tubular member, the inner member comprising an elongate body defining an inner passageway adapted to slideably receive a wireguide, a chamber for receiving an expandable intraluminal medical device, and a distal tip adapted for navigation through a body vessel, the chamber having a second proximal end and a second distal end; an expandable intraluminal medical device disposed on the inner member at the chamber; and an evertable sleeve attached to the inner member proximal to the chamber and to the inner surface of the tubular member at the distal end.
  • A delivery system according to a second embodiment comprises a tubular member having a proximal end defining a proximal opening, a distal end defining a distal opening, and an inner surface defining a passageway extending between the proximal and distal openings; an inner member slideably disposed within the passageway of the tubular member, the inner member comprising an elongate body defining an inner passageway adapted to slideably receive a wireguide, a chamber for receiving an expandable intraluminal medical device, and a distal tip adapted for navigation through a body vessel, the chamber having a second proximal end and a second distal end and comprising an axial section of the inner member having a reduced diameter as compared to a proximal portion of the inner member; an expandable intraluminal medical device disposed on the inner member at the chamber; and an evertable sleeve attached to the inner member proximal to the chamber and to the inner surface of the tubular member at the distal end.
  • A delivery system according to a third embodiment comprises a tubular member having a proximal end defining a proximal opening, a distal end defining a distal opening, and an inner surface defining a passageway extending between the proximal and distal openings; an inner member slideably disposed within the passageway of the tubular member, the inner member comprising an elongate body defining an inner passageway adapted to slideably receive a wireguide, a chamber for receiving an expandable intraluminal medical device, and a distal tip adapted for navigation through a body vessel, the chamber having a second proximal end and a second distal end and comprising an axial section of the inner member having a reduced diameter as compared to a proximal portion of the inner member; an expandable intraluminal medical device disposed on the inner member at the chamber; and an evertable sleeve attached to the inner member proximal to the chamber and to the inner surface of the tubular member at the distal end; the evertable sleeve comprising a flexible tubular member having a second proximal end and a second distal end embedded within a flange having a rounded inner edge; the second proximal end extends proximally along a portion of the inner member proximal to the chamber; and the second distal end extends distally along a portion of the inner surface of the tubular member toward the distal end.
  • Additional understanding of these and other embodiments can be obtained with review of the detailed description, below, and the appended drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a delivery system according to a first embodiment.
  • FIG. 2 is a sectional view of the distal end of the delivery system illustrated in FIG. 1. An associated intraluminal medical device is illustrated in a partially deployed state.
  • FIG. 2A is a magnified view of the area indicated in FIG. 2.
  • FIG. 2B is a magnified sectional view of the distal end of a delivery system according to an alternative embodiment.
  • FIG. 3 is a sectional view of the distal end of a delivery system according to a second embodiment. An associated intraluminal medical device is illustrated in a partially deployed state.
  • FIG. 4 is a sectional view of the distal end of a delivery system according to a third embodiment. An associated intraluminal medical device is illustrated in a partially deployed state.
  • FIG. 5 is a partial sectional view of the distal end of a delivery system according to a fourth embodiment. An associated intraluminal medical device is illustrated in a partially deployed state.
  • FIG. 6 is a partial sectional view of the distal end of a delivery system according to a fifth embodiment. An associated intraluminal medical device is illustrated in a partially deployed state.
  • FIG. 6A is a magnified view of the area indicated in FIG. 6.
  • FIG. 7 is a magnified sectional view of the distal end of a delivery system according to an alternative embodiment.
  • DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
  • The following detailed description and the appended drawings describe and illustrate various exemplary embodiments of the invention. The description and drawings are exemplary in nature and are provided to enable one skilled in the art to make and use one or more embodiments according to the disclosure. They are not intended to limit the scope of the claims in any manner.
  • As used herein, the term “evertable” refers to the ability to have an inner surface turned outward.
  • FIGS. 1, 2, and 2A illustrate a delivery system 10 according to a first embodiment. The delivery system 10 includes an elongate sheath or tubular member 12 having a distal end 14 which is insertable in a body vessel and a proximal end 16 that can be coupled to a connector 18 such as a Touhy Borst adapter or any other suitable functional connectors, adapters, and the like. A passageway or lumen 20 extends from the distal end 14 to the proximal end 16 and permits relative axial movement of components contained therein, such as dilator 22, described below.
  • Dilator 22 or another suitable inner member is disposed within the passageway 20 defined by the tubular member 12. As used herein, the term “dilator” refers to an elongate member capable of being disposed within a lumen of a sheath, such as the tubular member 12, and adapted to have an intraluminal medical device positioned thereon, as described in detail below. The dilator 22 has a distal tip 24 that defines a tapered distal end 26. The distal end 26 provides an atraumatic structure that facilitates insertion of the delivery system 10 into a body vessel and subsequent navigation of the delivery system 10 through the body vessel. A proximal end 28 of the dilator 22 can include one or more structures that facilitate handling of the dilator 22 and/or delivery system 10, such as tab 30.
  • A lumen 32 is formed by the dilator 22 and extends along the entire length of the dilator 22, from the distal end 26 to the proximal end 28. Distal 34 and proximal 36 openings defined by the dilator 22 provide access to the lumen 32. The lumen 32 is adapted to receive a wireguide (not shown) or any other suitable member, therein. As used herein, the term “wireguide” refers to elongate members used in minimally invasive procedures to define a path along which other devices can be advanced. The term is considered equivalent in meaning to the term “guidewire” as used in the art. The lumen 32 aids in guiding the delivery system 10 through a body vessel to a desired point of treatment by ensuring that axial advancement of the delivery system 10 occurs only along the path defined by a previously placed wireguide.
  • While the embodiment illustrated in FIGS. 1, 2 and 2A includes a lumen 26 that extends along the entire length of the dilator, it is understood that an alternative lumen can be used. For example, a lumen that extends along only a portion of the length of the dilator 22 can be used. Indeed, over-the-wire, rapid exchange, short wire and intraductal exchange type delivery systems are contemplated and considered to be within the scope of the invention.
  • In use, the delivery system 10 is placed over a wireguide that has been placed in a body vessel such that a distal end of the wireguide is near or beyond a desired point of treatment relative to a point at which the wireguide enters the vessel. The delivery system 10 is placed over the wireguide by passing the proximal end of the wireguide into the distal opening 34 of the dilator 22 and into the lumen 32. The delivery system 10 is then advanced along the wireguide and through the vessel until a desired positioning of a portion of the delivery system 10, such as an portion containing a carried intraluminal medical device, relative to a point of treatment is achieved.
  • The tubular member 12 and dilator 22 are made of suitable materials currently known in the art or hereinafter developed. The selection of materials for these elements need only address the desired flexibility and biocompatibility recognized as design concerns for medical device delivery systems. A skilled artisan will be able to select suitable materials for these elements based on various considerations, including the environment in which a particular delivery system according to an embodiment is intended to be used and other considerations. Examples of suitable materials include polymeric materials, such as polypropylene and nylon, extruded or otherwise formed into the desired structures.
  • As best illustrated in FIG. 2, the dilator 22 defines a device chamber 40 for receiving an expandable intraluminal medical device 42. In the illustrated embodiment, the chamber 40 is positioned proximal to the distal tip 24 and comprises an axial section 44 along the length of the dilator 22 having a reduced diameter as compared to the proximal portion 46 of the dilator 22. While this structure of the chamber 40 is considered advantageous for use with some expandable intraluminal medical devices, such as those including an attached graft member or other component that increases the overall bulk of the expandable intraluminal medical device, alternative structures can be used. For example, the chamber 40 can comprise a simple mounting region having the same diameter as the remainder of the dilator 22 proximal to the distal tip 24. In these embodiments, which are considered advantageous for use with expandable support frames, stents, and other devices without attached graft members, the expandable intraluminal medical device is simply positioned on the mounting region of the dilator 22.
  • While the expandable intraluminal medical device 42 is illustrated as an expandable stent, it is expressly understood that any suitable expandable intraluminal medical device can be used in delivery systems according to the invention. Further, the intraluminal medical device 42 can be a self-expandable device or a device that requires an input of force for expansion, such as a balloon-expandable device. Examples of expandable intraluminal medical devices that can be used in the delivery systems disclosed herein include stents, stent grafts, valve devices, occluders, expandable filters, distal protection devices, and the like. The delivery systems described herein are believed to be particularly well-suited for use with expandable intraluminal medical devices that include a graft member attached to a support frame. As used herein, the term “graft member” refers to natural and synthetic sections of material, such as polymeric materials, natural tissue, and other flexible sections of material. Examples of such devices include stent grafts and prosthetic valves. Specific examples of suitable self-expandable medial devices for use with delivery systems according to the invention include those described in U.S. Pat. No. 6,200,336 to Pavcnik et al. for a MULTIPLE-SIDED INTRALUMINAL MEDICAL DEVICE; U.S. patent application Ser. No. 10/642,372 of Pavcnik et al. for an IMPLANTABLE VASCULAR DEVICE, filed on Aug. 15, 2003; and U.S. patent application Ser. No. 10/828,716 of Case et al. for an ARTIFICIAL VALVE PROSTHESIS WITH IMPROVED FLOW DYNAMICS, filed on Apr. 21, 2004; the entire disclosures of which are hereby incorporated into this disclosure for the purpose of describing suitable self-expandable medical devices for use with delivery systems according to the invention.
  • As best illustrated in FIG. 2A, an evertable sleeve 50 is positioned between the tubular member 12 and the dilator 22. The evertable sleeve 50 is a flexible tubular member having distal 52 and proximal 54 ends. An outer surface 56 of the distal end 52 is attached to an inner surface 58 of the distal end 14 of the tubular member 12, while an inner surface 60 of the proximal end 54 is attached to an outer surface 62 of the dilator 22 at a point proximal to the device chamber 40 or other portion of the dilator 22 with which the expandable intraluminal medical device 42 is associated. The details of the attachment illustrated in the figures are described in further detail below. This structural arrangement allows an inner surface 64 of the evertable sleeve 50 to be positioned adjacent the expandable intraluminal medical device 42 while in the device chamber 40 or other suitable region of the dilator 22. As will be described below, this positioning of the inner surface 64 shields the expandable intraluminal medical device from contact with the tubular member 12 and the friction that would be created between the tubular member 12 and the expandable intraluminal medical device in the absence of the evertable sleeve. Furthermore, the structural arrangement between the evertable sleeve 50, the tubular member 12 and the dilator 22 allows the formation of rolling bend 66 in the evertable sleeve 50.
  • In the embodiment illustrated in FIG. 2A, the outer surface 56 at the distal end 52 of the evertable sleeve 50 and the inner surface 60 at the proximal end 54 of the evertable sleeve 50 are portions of the same continuous surface of the sleeve 50.
  • The attachment between the distal end 52 of the evertable sleeve 50 and the inner surface 58 of the distal end 14 of the tubular member 12 avoids various disadvantages that might result from attaching the distal end 52 to an exterior surface of the tubular member 12. For example, an attachment to the exterior surface of the tubular member 12 would increase the overall exterior diameter of the delivery system 10 at the point of attachment, which might affect the use of the delivery system 10 in certain body vessels. Furthermore, such an attachment would likely produce an irregularity on the exterior surface of the tubular member 12 that might cause irritation or other damage to a body vessel as a result of navigation of the delivery system 10 therethrough.
  • FIG. 2B illustrates an alternative structure for the attachment between the evertable sleeve and the tubular member. In contrast to the embodiment illustrated in FIG. 2A, the outer surface 56′ at the distal end 52′ of the evertable sleeve 50′ and the inner surface 60′ at the proximal end 54′ of the evertable sleeve 50′ are portions of opposing surfaces of the sleeve 50′. This alternative embodiment is discussed in detail below.
  • As best illustrated in FIG. 2A, the distal end 52 of the sleeve 50 is embedded in a distal flange 68 and the proximal end 54 is embedded in a proximal flange 70. While the inclusion of the flanges 68, 70 is considered optional, their inclusion is considered advantageous at least because the embedding of the ends 52, 54 of the evertable sleeve 50 therein is expected to increase the overall durability of the attachments between the sleeve 50 and the tubular member 12 and the dilator 22 by avoiding direct attachment between these elements. One or both flanges 68, 70 can be included. If included, the flanges 68, 70 advantageously comprise ring structures formed of polymeric material within which a portion of the evertable sleeve 50, such as an end, can be embedded, such as during manufacturing of the delivery system 10. A continuous ring structure is considered advantageous for the flanges 68, 70 at least because it maximizes the surface area for contact between the flanges 68, 70 and the tubular member and/or dilator 22. Intermittent or partial ring structures can be used, though, and may be desirable in particular embodiments.
  • The flanges 68, 70 are attached to the tubular member 12 and dilator 22, as appropriate, with adhesive 72 or other suitable means for attaching the material of the flanges 68, 70 to the material of the tubular member 12 and the dilator 22. Use of an adhesive is considered advantageous at least because of the availability of a wide range of biocompatible adhesives. Other suitable means for attaching the flanges 68, 70 to the tubular member 12 and dilator 22 include mechanical attachment elements, such as sutures, weld joints, fusion joints, such as joints formed by melting and joining the components together, and other suitable elements and processes for attaching the materials of these elements together. Furthermore, while the figures illustrate both flanges 68, 70 as being attached to the appropriate one of the tubular member 12 and the dilator 22, it is expressly understood that different means for attaching could be used for the flanges 68, 70. For example, the distal flange 68 could be attached to the tubular member 12 with an adhesive while the proximal flange 70 could be attached to the dilator 12 with a mechanical means for attaching, such as a circumferential retainer clip.
  • FIG. 7 illustrates an alternate embodiment in which the tubular member 12 defines a first recess 91 and the dilator 22 defines a second recess 93. The distal flange 68 is positioned within the first recess 91 and attached to the tubular member with adhesive 72. Similarly, the proximal flange 70 is positioned within the second recess 93 and attached to the dilator 22 with adhesive 72. While the structures illustrated in the other figures is regarded to be within the scope of the invention, the structure illustrated in FIG. 7 is considered advantageous at least because it substantially removes the adhesive 72 and flanges 70 from the interior space between the tubular member 12 and dilator 22. This arrangement is expected to facilitate movement of the evertable sleeve 50 as described herein. It is expressly understood that this optional structural arrangement of the elements can be used with any embodiment described herein.
  • FIG. 2B illustrates an alternative embodiment in which the distal end 52′ of the evertable sleeve 50′ is embedded in a proximal end 69′ of the distal flange 68′. Also, the proximal end 69′ of the distal flange 68′ includes a rounded inner edge 71′. This arrangement lessens the tension placed on the evertable sleeve 50′ during retraction of the tubular member 12 by forcing the distal end 52′ of the evertable sleeve to wrap around the distal flange 68′ during such retraction. Furthermore, the presence of the rounded inner edge 71′ eliminates an angled surface that might otherwise cause damage to the sleeve 50′ when in contact with the distal flange 68′. As a result of this structural arrangement, the evertable sleeve forms first 66′ and second 67′ rolling bends.
  • The evertable sleeve 50 can be formed of any suitable material, and a skilled artisan will be able to select an appropriate material based or various considerations, such as the nature of the expandable intraluminal medical device, the environment in which the device is intended to be implanted, and others. The evertable sleeve is advantageously formed of a material that is able to slide against itself and that is sufficiently flexible to form one or more rolling bends during operation of the delivery system, as described above. Examples of materials that are currently considered suitable include ePTFE, nylon, polyethylene, and other polymeric materials. Polyethylene materials are considered particularly advantageous at least because of their bi-axial long-chain structures, which provides beneficial strength characteristics. Materials coated with a lubricious coating are also considered suitable. The sleeve 50 can also have any suitable configuration, including a tubular configuration with uniform inner and/or outer diameters. A tapered sleeve, i.e., a sleeve with an inner and/or outer diameter that varies along an axial length of the sleeve, is believed to be advantageous in that the tapered structure is expected to facilitate movement of the sleeve as described herein. Embodiments in which the sleeve comprises a tapered sleeve, with a first end have a relatively large inner and/or outer diameters is attached to a tubular member as described herein and a second end having a relatively small inner and/or outer diameters is attached to the dilator are believed to be particularly advantageous in that movement of the sleeve as described herein is expected to be facilitated by this arrangement.
  • The flanges can comprise portions of the evertable sleeve 50 or can be separately attached members, as illustrated in the figures. For example, the flanges can comprise thickened portions of the sleeve 50, treated portions of the sleeve 50, or a polymeric or other structure into which portions, such as an end 52, 54, have been placed. Also, other structures can be used as alternatives to the tubular evertable sleeve 50. For example, two or more strips of material can be attached to the components of and positioned within the delivery system as described herein. A sleeve with lengthwise, partial circumferential, and diagonal (all with respect to a lengthwise axis of the sleeve) slits or other structural disruptions in the surface can also be used.
  • FIG. 3 illustrates a delivery system 110 according to another exemplary embodiment. The delivery system 110 according to this embodiment is similar to the delivery system 10 illustrated in FIGS. 1, 2 and 2A and described above, except as detailed below. Thus, the delivery system 110 includes an elongate sheath or tubular member 112 having distal 114 and proximal (not illustrated in FIG. 3) ends and a passageway or lumen 120 that extends between the ends. A dilator 122 is disposed within the passageway 120 and has a distal tip 124 that defines a tapered distal end 126. A lumen 132 extends along the entire length of the dilator 122 and distal 134 and proximal (not illustrated in FIG. 3) openings provide access to the lumen 132. A device chamber 140 receives an expandable intraluminal medical device 142. An evertable sleeve 150 is positioned between the tubular member 112 and the dilator 122.
  • In this embodiment, the distal end 152 of the evertable sleeve 150 is attached to the inner surface 158 of the distal end 114 of the tubular member 112 by retaining ring 180. The retaining ring 180 is a circumferential member that is friction fit into a circumferential groove 182 defined by the inner surface 158 of the tubular member 112. In the embodiment illustrated in FIG. 3, the distal end 152 of the evertable sleeve 150 is embedded into the distal side 184 of the retaining ring 180. As illustrated in the Figure, the distal end 152 is positioned such that the distal end 152 of the sleeve 150 extends distally with respect to the tubular member 112 and lies substantially parallel to the inner surface of the inner surface 158 of the tubular member 112.
  • In an alternative embodiment, the distal end 152 of the evertable sleeve 150 is embedded into the proximal side 186 of the retaining ring 180—substantially the opposite of the configuration illustrated in FIG. 3. In this embodiment, the distal end 152 of the evertable sleeve 150 extends proximally with respect to the tubular member 112 and wraps around the inner surface 188 of the retaining ring 180. Similar to the embodiment illustrated in FIG. 2B, this structural arrangement is considered advantageous at least because, as compared to the embodiment illustrated in FIGS. 1, 2, and 2A, it is believed to lessen the tension placed on the evertable sleeve 150 during retraction of the tubular member 112. Also, as illustrated in FIG. 3, the inner surface 188 can advantageously define an outer curve to minimize the potential effect of angles on the evertable sleeve 150 while in contact with the surface 188. Furthermore, this alternate structural arrangement achieves this desirable effect on the tension placed on the evertable sleeve 150 while avoiding the introduction of multiple rolling bends, as with the embodiment illustrated in FIG. 2B. While the existence of multiple rolling bends is not considered particularly disadvantageous, the presence of multiple bends is expected to affect the overall bulk and complexity of the delivery system components. As such, for delivery systems for which these factors are a concern, construction according to the structural arrangement according to this embodiment may provide advantages.
  • FIG. 4 illustrates a delivery system 210 according to another exemplary embodiment. The delivery system 210 according to this embodiment is similar to the delivery system 10 illustrated in FIGS. 1, 2 and 2A and described above, except as detailed below. Thus, the delivery system 210 includes an elongate sheath or tubular member 212 having distal 214 and proximal (not illustrated in FIG. 4) ends and a passageway or lumen 220 that extends between the ends. A dilator 222 is disposed within the passageway 220 and has a distal tip 224 that defines a tapered distal end 226. A lumen 232 extends along the entire length of the dilator 222 and distal 234 and proximal (not illustrated in FIG. 4) openings provide access to the lumen 232. A device chamber 240 receives an expandable intraluminal medical device 242. An evertable sleeve 250 is positioned between the tubular member 212 and the dilator 222.
  • In this embodiment the distal end 252 of the evertable sleeve 250 is attached to pull wires 290, 292. The pull wires 290, 292 extend proximally through the passageway 220 defined by the tubular member 212 and extends out of the proximal end (not illustrated) of the tubular member 212. This structural arrangement allows a user to retract the evertable sleeve 250 by retracting the pull wires 290, 292 relative to the dilator 222. As illustrated in FIG. 4, the distal end 252 of the evertable sleeve 250 advantageously includes a distal flange 268 as described above. The inclusion of the flange is believed to increase the ruggedness of the connection between the pull wires 290, 292 and the flange 268, which can be formed in any suitable manner, including with adhesives and other bonding agents and/or techniques, by passing the wires 290, 292 through the thickness of the flange 268 and crimping, tying or otherwise fastening the wires 290, 292 to themselves, or with other suitable structures or techniques for attaching wire members to sheet-like material. The pull wires 290, 292 can be formed of any suitable material including metallic wire, string, etc. No limitation on material is contemplated by use of the term “wire”. Furthermore, while two pull wires spaced equidistatatly from a lengthwise axis of the sleeve and on the same plane are illustrated in the Figure, any suitable number and configuration of wire(s) can be used.
  • The use of pull wires 290, 292 to control the evertable sleeve 250 may be advantageous in which it is desirable to control the position of the sleeve 250 relative to the expandable intraluminal medical device independent of the position of the tubular member 212.
  • FIG. 5 illustrates a delivery system 310 according to another exemplary embodiment. The delivery system 310 according to this embodiment is similar to the delivery system 10 illustrated in FIGS. 1, 2 and 2A and described above, except as detailed below. Thus, the delivery system 310 includes an elongate sheath or tubular member 312 having distal 314 and proximal (not illustrated in FIG. 5) ends and a passageway or lumen 320 that extends between the ends. A dilator 322 is disposed within the passageway 320 and has a distal tip 324 that defines a tapered distal end 326. A lumen 332 extends along the entire length of the dilator 322 and distal 334 and proximal (not illustrated in FIG. 5) openings provide access to the lumen 332. A device chamber 340 receives an expandable intraluminal medical device 342. An evertable sleeve 350 is positioned between the tubular member 312 and the dilator 322.
  • In this embodiment the distal end 352 of the evertable sleeve 350 is attached to an internal tubular member 395 that is disposed within the passageway 320 defined by the sheath or outer tubular member 312 and extends out of the proximal end (not illustrated) of the tubular member 312. This structural arrangement allows a user to retract the evertable sleeve 350 by retracting the inner tubular member 395 relative to the dilator 322. The distal end 352 of the evertable sleeve 350 is attached to the outer surface of the internal tubular member 395, such as by adhesives, thermal bonding, or other suitable attachments. Alternatively, the internal tubular member 395 can be an extension of the evertable sleeve 350, and indeed the internal tubular member 395 and evertable sleeve 350 can comprise a continuous unitary sleeve. Similarly, the proximal end 354 of the evertable sleeve 350 is attached to an outer surface of the dilator 322.
  • The inclusion of the internal tubular member 395 to control the evertable sleeve 350 is considered advantageous at least because it provides the ability to control the position of the sleeve 350 relative to the expandable intraluminal medical device 342 independent of the position of the tubular member 212, as described above in connection with the embodiment illustrated in FIG. 4, without the inclusion of wire members. A tubular structure may provide additional control over that provided by one or more wire members, as described above, at least because it requires manipulation of only a single element to affect positioning of the sleeve 350 relative to the expandable intraluminal medical device, as opposed to requiring manipulation of two or more members.
  • FIGS. 6 and 6A illustrate a delivery system 410 according to another exemplary embodiment. The delivery system 410 according to this embodiment is similar to the delivery system 310 illustrated in FIG. 5 and described above, except as detailed below. Thus, the delivery system 410 includes an elongate sheath or tubular member 412 having distal 414 and proximal (not illustrated in FIG. 6) ends and a passageway or lumen 420 that extends between the ends. A dilator 422 is disposed within the passageway 420 and has a distal tip 424 that defines a tapered distal end 426. A lumen 432 extends along the entire length of the dilator 422 and distal 434 and proximal (not illustrated in FIG. 6) openings provide access to the lumen 432. A device chamber 440 receives an expandable intraluminal medical device 442. An evertable sleeve 450 is positioned between the tubular member 412 and the dilator 422.
  • In this embodiment the evertable sleeve 450 comprises separate individual flaps 480, 482. Proximal ends 484, 486 of the flaps 480, 482 are attached to an outer surface of the dilator 422. Distal ends 488, 490 the flaps 480, 482 are attached to an internal tubular member 495 that is disposed within the passageway 420 defined by the sheath or outer tubular member 412 and extends out of the proximal end (not illustrated) of the tubular member 412. As best illustrated in FIG. 6A, the distal ends 488, 490 of the flaps 480, 482, and the distal end of the internal tubular member 495 can be attached, either directly or via an attachment to each other, to a separate flange member, such as circumferential flange 492.
  • While two separate flaps are illustrated in the figure, any suitable number, configuration and arrangement of flaps can be used and a skilled artisan will be able to determine acceptable numbers, configurations, and arrangements for particular embodiments based on various considerations, including the nature of the expandable intrluminal medical device with which the delivery system is used or intended to be used.
  • The foregoing detailed description provides exemplary embodiments of the invention and includes the best mode for practicing the invention. The description and illustration of embodiments is intended only to provide examples and not to limit the scope of the claims in any manner.

Claims (24)

1. A medical device delivery system, comprising:
a tubular member having a proximal end defining a proximal opening, a distal end defining a distal opening, and an inner surface defining a passageway extending between the proximal and distal openings;
an inner member slideably disposed within the passageway of the tubular member, the inner member comprising an elongate body defining an inner passageway adapted to slideably receive a wireguide, a chamber for receiving an expandable intraluminal medical device, and a distal tip adapted for navigation through a body vessel, the chamber having a second proximal end and a second distal end;
an expandable intraluminal medical device disposed on the inner member at the chamber; and
an evertable sleeve attached to the inner member proximal to the chamber and to the inner surface of the tubular member at the distal end, the evertable sleeve comprising a flexible tubular member adapted to move between a first position substantially overlying the expandable intraluminal medical device between the chamber and the inner surface of the tubular member and a second position substantially proximal to the chamber upon relative axial movement among the tubular member and the inner member.
2. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second inner surface having first and second end portions, the first end portion attached to the inner member and the second end portion attached to the inner surface of the tubular member.
3. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second inner surface, an outer surface, a second proximal end, and a second distal end, the second proximal end of the second inner surface attached to the inner member and the second distal end of the outer surface attached to the inner surface of the tubular member.
4. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second proximal end and a second distal end; and
wherein at least one of the second proximal and second distal ends comprises a flange.
5. The medical device delivery system according to claim 4, wherein the flange comprises a circumferential ring structure.
6. The medical device delivery system according to claim 4, wherein the flange comprises a partial circumferential ring structure.
7. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second proximal end and a second distal end; and
wherein at least one of the second proximal and second distal ends is embedded within a flange.
8. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second proximal end and a second distal end; and
wherein the second distal ends is embedded within a flange; and
wherein the flange includes a rounded inner edge.
9. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second proximal end and a second distal end; and
wherein the second proximal end extends proximally along a portion of the inner member proximal to the chamber; and
wherein the second distal end extends proximally along a portion of the inner surface of the tubular member.
10. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second proximal end and a second distal end; and
wherein the second proximal end extends proximally along a portion of the inner member proximal to the chamber; and
wherein the second distal end extends distally along a portion of the inner surface of the tubular member toward the distal end.
11. The medical device delivery system according to claim 1, wherein the sleeve comprises ePTFE, nylon, or another polymeric material.
12. The medical device delivery system according to claim 1, wherein the expandable intraluminal medical device comprises a self-expandable intraluminal medical device.
13. The medical device delivery system according to claim 1, wherein the expandable intraluminal medical device requires an application of an expansion force to effect expansion.
14. The medical device delivery system according to claim 1, wherein the expandable intraluminal medical device includes a graft member.
15. The medical device delivery system according to claim 14, wherein the expandable intraluminal medical device comprises a stent graft device, an occluder, a prosthetic valve, or an expandable filter.
16. The medical device delivery system according to claim 1, wherein the chamber comprises an axial section of the inner member having a reduced diameter as compared to a proximal portion of the inner member.
17. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second proximal end and a second distal end; and
wherein the second proximal end is embedded in a first flange having a third proximal end and a third distal end and the second distal end is embedded in a second flange having a fourth proximal end and a fourth distal end, the second proximal end embedded in the third distal end of the first flange and the second distal end embedded in the fourth distal end of the second flange.
18. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second proximal end and a second distal end; and
wherein the second proximal end is embedded in a first flange having a third proximal end and a third distal end and the second distal end is embedded in a second flange having a fourth proximal end and a fourth distal end, the second proximal end embedded in the third distal end of the first flange and the second distal end embedded in the fourth proximal end of the second flange.
19. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second outer surface, a second inner surface, a second proximal end and a second distal end; and
wherein the second proximal end has a third surface facing inward toward the inner member and the second distal end has a fourth surface facing outward toward the tubular member, the third surface and the fourth surface each being a portion of the second outer surface.
20. The medical device delivery system according to claim 1, wherein the evertable sleeve has a second outer surface, a second inner surface, a second proximal end and a second distal end; and
wherein the second proximal end has a third surface facing inward toward the inner member and the second distal end has a fourth surface facing outward toward the tubular member, the third surface being a portion of the second outer surface and the fourth surface being a portion of the second inner surface.
21. A medical device delivery system, comprising:
a tubular member having a proximal end defining a proximal opening, a distal end defining a distal opening, and an inner surface defining a passageway extending between the proximal and distal openings;
an inner member slideably disposed within the passageway of the tubular member, the inner member comprising an elongate body defining an inner passageway adapted to slideably receive a wireguide, a chamber for receiving an expandable intraluminal medical device, and a distal tip adapted for navigation through a body vessel, the chamber having a second proximal end and a second distal end and comprising an axial section of the inner member having a reduced diameter as compared to a proximal portion of the inner member;
an expandable intraluminal medical device disposed on the inner member at the chamber; and
an evertable sleeve attached to the inner member proximal to the chamber and to the inner surface of the tubular member at the distal end, the evertable sleeve comprising a flexible tubular member adapted to move between a first position substantially overlying the expandable intraluminal medical device between the chamber and the inner surface of the tubular member and a second position substantially proximal to the chamber upon relative axial movement among the tubular member and the inner member.
22. The medical device delivery system according to claim 21, wherein the evertable sleeve has a second inner surface having first and second end portions, the first end portion attached to the inner member and the second end portion attached to the inner surface of the tubular member.
23. The medical device delivery system according to claim 21, wherein the evertable sleeve has a second inner surface, an outer surface, a second proximal end, and a second distal end, the second proximal end of the second inner surface attached to the inner member and the second distal end of the outer surface attached to the inner surface of the tubular member.
24. A medical device delivery system, comprising:
a tubular member having a proximal end defining a proximal opening, a distal end defining a distal opening, and an inner surface defining a passageway extending between the proximal and distal openings;
an inner member slideably disposed within the passageway of the tubular member, the inner member comprising an elongate body defining an inner passageway adapted to slideably receive a wireguide, a chamber for receiving an expandable intraluminal medical device, and a distal tip adapted for navigation through a body vessel, the chamber having a second proximal end and a second distal end and comprising an axial section of the inner member having a reduced diameter as compared to a proximal portion of the inner member;
an expandable intraluminal medical device disposed on the inner member at the chamber; and
an evertable sleeve attached to the inner member proximal to the chamber and to the inner surface of the tubular member at the distal end, the evertable sleeve comprising a flexible tubular member having a second proximal end and a second distal end embedded within a flange having a rounded inner edge;
wherein the second proximal end extends proximally along a portion of the inner member proximal to the chamber; and
wherein the second distal end extends distally along a portion of the inner surface of the tubular member toward the distal end.
US12/833,604 2009-07-09 2010-07-09 Delivery system with medical device release by evertable sleeve Abandoned US20110009943A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US22436009P true 2009-07-09 2009-07-09
US12/833,604 US20110009943A1 (en) 2009-07-09 2010-07-09 Delivery system with medical device release by evertable sleeve

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/833,604 US20110009943A1 (en) 2009-07-09 2010-07-09 Delivery system with medical device release by evertable sleeve
US13/562,674 US8366761B2 (en) 2009-07-09 2012-07-31 Delivery system with medical device release by evertable sleeve

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/562,674 Continuation US8366761B2 (en) 2009-07-09 2012-07-31 Delivery system with medical device release by evertable sleeve

Publications (1)

Publication Number Publication Date
US20110009943A1 true US20110009943A1 (en) 2011-01-13

Family

ID=43428084

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/833,604 Abandoned US20110009943A1 (en) 2009-07-09 2010-07-09 Delivery system with medical device release by evertable sleeve
US13/562,674 Active US8366761B2 (en) 2009-07-09 2012-07-31 Delivery system with medical device release by evertable sleeve

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/562,674 Active US8366761B2 (en) 2009-07-09 2012-07-31 Delivery system with medical device release by evertable sleeve

Country Status (1)

Country Link
US (2) US20110009943A1 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110034987A1 (en) * 2009-08-04 2011-02-10 Kennedy Kenneth C Roll sleeve mechanism for proximal release stent
US20130116721A1 (en) * 2010-06-30 2013-05-09 Terumo Kabushiki Kaisha Medical Device
US20140025150A1 (en) * 2012-07-20 2014-01-23 Tyco Healthcare Group Lp Resheathable stent delivery system
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US9078659B2 (en) 2012-04-23 2015-07-14 Covidien Lp Delivery system with hooks for resheathability
US9192498B2 (en) 2012-02-23 2015-11-24 Covidien Lp Luminal stenting
WO2015187196A1 (en) * 2014-06-04 2015-12-10 Nfinium Vascular Technologies, Llc Low radial force vascular device and method of occlusion
US9474639B2 (en) 2013-08-27 2016-10-25 Covidien Lp Delivery of medical devices
US9636244B2 (en) * 2015-04-09 2017-05-02 Mubin I. Syed Apparatus and method for proximal to distal stent deployment
US9782186B2 (en) 2013-08-27 2017-10-10 Covidien Lp Vascular intervention system
US9849014B2 (en) 2002-03-12 2017-12-26 Covidien Lp Medical device delivery
US9980838B2 (en) 2015-10-30 2018-05-29 Ram Medical Innovations Llc Apparatus and method for a bifurcated catheter for use in hostile aortic arches
EP3236833A4 (en) * 2014-11-24 2018-10-24 Consis Medical Ltd. System, device and method for advancing an article along a path
US10130500B2 (en) 2013-07-25 2018-11-20 Covidien Lp Methods and apparatus for luminal stenting
US10173031B2 (en) 2016-06-20 2019-01-08 Mubin I. Syed Interchangeable flush/selective catheter
US10213329B2 (en) 2011-08-12 2019-02-26 W. L. Gore & Associates, Inc. Evertable sheath devices, systems, and methods
US10213187B1 (en) 2012-01-25 2019-02-26 Mubin I. Syed Method and apparatus for percutaneous superficial temporal artery access for carotid artery stenting

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9763819B1 (en) * 2013-03-05 2017-09-19 W. L. Gore & Associates, Inc. Tapered sleeve

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946440A (en) * 1988-10-05 1990-08-07 Hall John E Evertible membrane catheter and method of use
US5779670A (en) * 1995-05-31 1998-07-14 Bidwell; Robert E. Catheter having lubricated sheathing
US20010044595A1 (en) * 2000-05-02 2001-11-22 Wilson-Cook Medical, Inc. Introducer apparatus with eversible sleeve
US20050240254A1 (en) * 2004-04-27 2005-10-27 Michael Austin Stent delivery system
US20060030923A1 (en) * 2004-08-06 2006-02-09 Gunderson Richard C Stent delivery system
US20060041302A1 (en) * 2004-08-17 2006-02-23 Andrzej Malewicz Stent delivery system
US20090018637A1 (en) * 2007-07-11 2009-01-15 Paul Jr Ram H Tubular devices having reversible components for deployment of endoluminal occluders and related methods and systems
US20100168785A1 (en) * 2008-12-29 2010-07-01 Cook Incorporated Embolic protection device and method of use

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946440A (en) * 1988-10-05 1990-08-07 Hall John E Evertible membrane catheter and method of use
US5779670A (en) * 1995-05-31 1998-07-14 Bidwell; Robert E. Catheter having lubricated sheathing
US20010044595A1 (en) * 2000-05-02 2001-11-22 Wilson-Cook Medical, Inc. Introducer apparatus with eversible sleeve
US20050240254A1 (en) * 2004-04-27 2005-10-27 Michael Austin Stent delivery system
US20060030923A1 (en) * 2004-08-06 2006-02-09 Gunderson Richard C Stent delivery system
US20060041302A1 (en) * 2004-08-17 2006-02-23 Andrzej Malewicz Stent delivery system
US20090018637A1 (en) * 2007-07-11 2009-01-15 Paul Jr Ram H Tubular devices having reversible components for deployment of endoluminal occluders and related methods and systems
US20100168785A1 (en) * 2008-12-29 2010-07-01 Cook Incorporated Embolic protection device and method of use

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9849014B2 (en) 2002-03-12 2017-12-26 Covidien Lp Medical device delivery
US20110034987A1 (en) * 2009-08-04 2011-02-10 Kennedy Kenneth C Roll sleeve mechanism for proximal release stent
US20130116721A1 (en) * 2010-06-30 2013-05-09 Terumo Kabushiki Kaisha Medical Device
US10213329B2 (en) 2011-08-12 2019-02-26 W. L. Gore & Associates, Inc. Evertable sheath devices, systems, and methods
US10213187B1 (en) 2012-01-25 2019-02-26 Mubin I. Syed Method and apparatus for percutaneous superficial temporal artery access for carotid artery stenting
US9675488B2 (en) 2012-02-23 2017-06-13 Covidien Lp Luminal stenting
US9724221B2 (en) 2012-02-23 2017-08-08 Covidien Lp Luminal stenting
US9192498B2 (en) 2012-02-23 2015-11-24 Covidien Lp Luminal stenting
US9308110B2 (en) 2012-02-23 2016-04-12 Covidien Lp Luminal stenting
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US9949853B2 (en) 2012-04-23 2018-04-24 Covidien Lp Delivery system with hooks for resheathability
US9078659B2 (en) 2012-04-23 2015-07-14 Covidien Lp Delivery system with hooks for resheathability
US9724222B2 (en) * 2012-07-20 2017-08-08 Covidien Lp Resheathable stent delivery system
US20140025150A1 (en) * 2012-07-20 2014-01-23 Tyco Healthcare Group Lp Resheathable stent delivery system
US10130500B2 (en) 2013-07-25 2018-11-20 Covidien Lp Methods and apparatus for luminal stenting
US10045867B2 (en) 2013-08-27 2018-08-14 Covidien Lp Delivery of medical devices
US9827126B2 (en) 2013-08-27 2017-11-28 Covidien Lp Delivery of medical devices
US9775733B2 (en) 2013-08-27 2017-10-03 Covidien Lp Delivery of medical devices
US9474639B2 (en) 2013-08-27 2016-10-25 Covidien Lp Delivery of medical devices
US10092431B2 (en) 2013-08-27 2018-10-09 Covidien Lp Delivery of medical devices
US9782186B2 (en) 2013-08-27 2017-10-10 Covidien Lp Vascular intervention system
US10265207B2 (en) 2013-08-27 2019-04-23 Covidien Lp Delivery of medical devices
EP3151904A4 (en) * 2014-06-04 2018-02-14 Nfinium Vascular Technologies, LLC Low radial force vascular device and method of occlusion
WO2015187196A1 (en) * 2014-06-04 2015-12-10 Nfinium Vascular Technologies, Llc Low radial force vascular device and method of occlusion
EP3236833A4 (en) * 2014-11-24 2018-10-24 Consis Medical Ltd. System, device and method for advancing an article along a path
US9636244B2 (en) * 2015-04-09 2017-05-02 Mubin I. Syed Apparatus and method for proximal to distal stent deployment
US9980838B2 (en) 2015-10-30 2018-05-29 Ram Medical Innovations Llc Apparatus and method for a bifurcated catheter for use in hostile aortic arches
US10173031B2 (en) 2016-06-20 2019-01-08 Mubin I. Syed Interchangeable flush/selective catheter

Also Published As

Publication number Publication date
US20120296412A1 (en) 2012-11-22
US8366761B2 (en) 2013-02-05

Similar Documents

Publication Publication Date Title
EP0788802B1 (en) Titanium alloy self-expanding stent
EP1517651B1 (en) Thoracic aortic aneurysm stent graft
JP5619703B2 (en) Endoprosthesis deployment system for treating a vessel bifurcation
US5354310A (en) Expandable temporary graft
EP2555709B1 (en) Transcatheter heart valve delivery system with reduced area moment of inertia
US7264631B2 (en) Devices and methods for AAA management
EP1251797B1 (en) Stent introducer apparatus
JP4624103B2 (en) Stent graft delivery system
US7758626B2 (en) Device and method for delivering an endovascular stent-graft having a longitudinally unsupported portion
EP1673041B1 (en) Prosthesis deployment system retention device
ES2242132T3 (en) Stent and associated placement device.
EP2319459B1 (en) Heart valve delivery system
US7014653B2 (en) Furcated endovascular prosthesis
EP1771130B1 (en) Reduced deployment force delivery device
CA2878598C (en) Integrated heart valve delivery system
EP1885286B1 (en) Implant delivery system with interlocked rx port orientation
AU753962B2 (en) Endoluminal prosthesis and tissue separation condition treatment method
US20030233140A1 (en) Trigger wire system
EP1180002B1 (en) Stent delivery system for prevention of kinking, and method of loading same
US8048144B2 (en) Prosthesis fixation device and method
US20080114445A1 (en) Thoracic arch stent graft and method of delivery
EP1776066B1 (en) Stent having arcuate struts
US5902334A (en) Method and apparatus for recapture of hooked endoprosthesis
EP0873733A1 (en) Controllable stent delivery system
AU700717B2 (en) Cystoscope delivery system

Legal Events

Date Code Title Description
AS Assignment

Owner name: COOK INCORPORATED, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PAUL, RAM H;FENG, BRIAN P;BAILEY, FRANCES KRISTEN;AND OTHERS;SIGNING DATES FROM 20100721 TO 20100728;REEL/FRAME:024897/0219

AS Assignment

Owner name: COOK MEDICAL TECHNOLOGIES LLC, INDIANA

Free format text: CONFIRMATORY ASSIGNMENT;ASSIGNOR:COOK INCORPORATED;REEL/FRAME:028163/0310

Effective date: 20120504

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION